Related Experiment Videos
[Acute respiratory failure (ARDS) in a young child after drowning accident: therapy with exogenous surfactant and
Insights
Severe pediatric acute respiratory distress syndrome (ARDS) carries a high mortality risk. Exogenous surfactant and high-frequency oscillatory ventilation offer a potential life-saving treatment option for severe ARDS cases in children.
Area of Science:
- Pediatric critical care medicine
- Respiratory physiology
- Neonatal respiratory support
Background:
- Adult respiratory distress syndrome (ARDS) in children presents a significant mortality risk (55-85%), even with advanced ventilation techniques like positive end-expiratory pressure.
- Current treatment strategies for severe pediatric ARDS have limited efficacy, highlighting the need for novel therapeutic approaches.
Observation:
- A case study of a young boy (under 3 years old) experiencing severe ARDS subsequent to near-drowning is presented.
- The patient received treatment with exogenous surfactant and high-frequency oscillatory ventilation, methods typically used in neonatal care.
Findings:
- The combined treatment of exogenous surfactant and high-frequency oscillatory ventilation led to a favorable outcome in this severe pediatric ARDS case.
- This therapeutic approach, while effective, is limited by the high cost of surfactant therapy for patients beyond the neonatal period.
Implications:
- Exogenous surfactant and high-frequency oscillatory ventilation represent a potential last-resort treatment for severe pediatric ARDS outside the neonatal intensive care unit.
- Further research into cost-effective surfactant delivery methods is warranted to broaden accessibility for treating severe pediatric respiratory distress.
Abstract:
The adult respiratory distress syndrome (ARDS) in children has a very poor prognosis with a mortality risk of between 55 and 85%, in spite of improvements due to the introduction of positive endexpiratory pressure ventilation. We describe the clinical course of a not yet 3 year-old boy with severe ARDS following near-drowing. Treatment with exogenous surfactant and high frequency oscillatory ventilation, a well-established procedure in neonatology, was responsible for the favorable outcome. The high cost of surfactant therapy, however, is the main limiting factor for this kind of treatment in children beyond the neonatal period, but it may be the last therapeutic resort in the management of severe ARDS.